Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Iatrogenic Drug Events. Basic parameters: from 66 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Pharmacists working within a multidisciplinary team have a role to play in detecting the potential iatrogenic origin of a hospital admission, in order to implement measures to improve medication use appropriately and limit readmissions for medication-related iatrogenesis. The iatrogenic detection process depends on the individual involved, their experience, and any tools consulted. Indeed, detection aids have their place in this process and aim for better identification. For example, a questionnaire called AT HARM 10 was developed by a team of experienced pharmacists to identify hospitalizations related to medication-related iatrogenesis. The use of this tool has been validated for pharmacists as well as for pharmacy students: interns and fifth-year medical students. Identifying iatrogenic drug events among patients presenting to the emergency department using the AT HARM 10 grid in order to intervene and adapt therapeutic management. This clinical pharmacy activity complements what is already included in routine care (medication review, pharmaceutical analysis, and pharmaceutical intervention to adapt treatment).
Primary outcome measures
- Number of patients for whom an iatrogenic event was identified [Time frame: Up to 9 months]
Eligibility criteria
Inclusion criteria
- Adult patient (> 65 years old)
- Treated in the emergency department of Hautepierre Hospital
- Presenting a prioritization score > 7 according to the Von Korff score
- Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes.
Exclusion criteria
\- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
France · 1 center
- Service de Pharmacie - Stérilisation - CHU de Strasbourg - France — Strasbourg
Identifiers
NCT: NCT07333131 · 9542